Bloodwork question about aniracetam. Baseline, a year in, and the numbers moved in a direction I did not expect.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Cold storage, light protection, and a date on the vial. Boring, and it removes half the variables.
What the racetam class does pharmacologically does not require the subjective effect to be large to be real.
Vivid dreams are reported widely and are not in the label because there is not really a label.
The interesting question is not whether it works but for whom and at what cost.
Read methods.
Baseline first. Without a baseline the after picture is decoration.
Nobody has ever been talked out of a stack by a stranger on the internet.